Maternus-Kliniken Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Maternus-Kliniken.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 20.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) 25% Share Price Plunge Could Signal Some Risk
Aug 21
Maternus-Kliniken Aktiengesellschaft (ETR:MAK) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Jul 05A Piece Of The Puzzle Missing From Maternus-Kliniken Aktiengesellschaft's (ETR:MAK) Share Price
Mar 13Maternus-Kliniken (ETR:MAK) Will Be Hoping To Turn Its Returns On Capital Around
Jul 27The Returns On Capital At Maternus-Kliniken (ETR:MAK) Don't Inspire Confidence
Feb 22Some Investors May Be Worried About Maternus-Kliniken's (ETR:MAK) Returns On Capital
Jul 27Estimating The Fair Value Of Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Jun 10In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Maternus-Kliniken has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 107 | -7 | 13 | 19 | N/A |
| 3/31/2024 | 107 | -11 | 6 | 11 | N/A |
| 12/31/2023 | 102 | -14 | -1 | 3 | N/A |
| 9/30/2023 | 102 | -17 | -2 | 1 | N/A |
| 6/30/2023 | 102 | -19 | -2 | 0 | N/A |
| 3/31/2023 | 105 | -16 | 0 | 2 | N/A |
| 12/31/2022 | 107 | -14 | 2 | 4 | N/A |
| 9/30/2022 | 108 | -10 | 5 | 7 | N/A |
| 6/30/2022 | 110 | -6 | 8 | 11 | N/A |
| 3/31/2022 | 111 | -4 | 12 | 14 | N/A |
| 12/31/2021 | 111 | -3 | 15 | 17 | N/A |
| 9/30/2021 | 114 | -5 | 18 | 19 | N/A |
| 6/30/2021 | 116 | -7 | 20 | 21 | N/A |
| 3/31/2021 | 115 | -8 | 16 | 17 | N/A |
| 12/31/2020 | 114 | -10 | 11 | 12 | N/A |
| 9/30/2020 | 116 | -10 | 9 | 9 | N/A |
| 6/30/2020 | 117 | -10 | 6 | 7 | N/A |
| 3/31/2020 | 121 | -10 | 10 | 11 | N/A |
| 12/31/2019 | 124 | -10 | 15 | 16 | N/A |
| 9/30/2019 | 125 | -7 | 12 | 13 | N/A |
| 6/30/2019 | 125 | -5 | 10 | 11 | N/A |
| 3/31/2019 | 125 | -3 | 8 | 8 | N/A |
| 12/31/2018 | 124 | -2 | 5 | 6 | N/A |
| 9/30/2018 | 125 | -2 | 8 | 9 | N/A |
| 6/30/2018 | 126 | -2 | 11 | 12 | N/A |
| 3/31/2018 | 126 | -2 | N/A | 11 | N/A |
| 12/31/2017 | 127 | -1 | N/A | 10 | N/A |
| 9/30/2017 | 127 | 0 | N/A | 7 | N/A |
| 6/30/2017 | 126 | 2 | N/A | 5 | N/A |
| 3/31/2017 | 125 | 1 | N/A | 6 | N/A |
| 12/31/2016 | 124 | 1 | N/A | 8 | N/A |
| 9/30/2016 | 124 | 4 | N/A | 4 | N/A |
| 6/30/2016 | 124 | 2 | N/A | 6 | N/A |
| 3/31/2016 | 124 | 2 | N/A | -1 | N/A |
| 12/31/2015 | 123 | 2 | N/A | -3 | N/A |
| 9/30/2015 | 123 | 28 | N/A | 2 | N/A |
| 6/30/2015 | 124 | 28 | N/A | 2 | N/A |
| 3/31/2015 | 123 | 28 | N/A | 8 | N/A |
| 12/31/2014 | 122 | 27 | N/A | 11 | N/A |
| 9/30/2014 | 120 | -9 | N/A | 12 | N/A |
| 6/30/2014 | 118 | -10 | N/A | 10 | N/A |
| 3/31/2014 | 115 | -11 | N/A | 11 | N/A |
| 12/31/2013 | 114 | -13 | N/A | 7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MAK's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if MAK's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if MAK's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MAK's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if MAK's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MAK's Return on Equity is forecast to be high in 3 years time